BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 19913833)

  • 1. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
    Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH
    J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial comment.
    Nieder AM
    J Urol; 2010 Jan; 183(1):61. PubMed ID: 19913834
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy.
    Freifeld Y; Ghandour R; Singla N; Woldu S; Bagrodia A; Lotan Y; Rapoport LM; Gazimiev M; Delafuente K; Kulangara R; Robyak H; Petros FG; Raman JD; Matin SF; Margulis V
    Urol Oncol; 2020 Sep; 38(9):737.e11-737.e16. PubMed ID: 32641241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravesical instillation of epirubicin in the prophylactic treatment of recurrent superficial bladder cancer].
    Kobayashi M; Sugaya Y; Yuzawa M; Morita T; Kobayashi Y; Tokue A
    Hinyokika Kiyo; 1998 Dec; 44(12):861-4. PubMed ID: 10028430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial).
    O'Brien T; Ray E; Singh R; Coker B; Beard R;
    Eur Urol; 2011 Oct; 60(4):703-10. PubMed ID: 21684068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomy.
    Moriarty MA; Uhlman MA; Bing MT; O'Donnell MA; Brown JA; Tracy CR; Deorah S; Nepple KG; Gupta A
    BMC Urol; 2015 May; 15():45. PubMed ID: 26018765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y
    Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
    Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S
    J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Different Prophylactic Intravesical Chemotherapy Regimens for Bladder Cancer Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinomas: A Retrospective 2-center Study.
    Huang Y; Cen J; Liu Z; Wei J; Chen Z; Feng Z; Lu J; Fang Y; Zhou F; Luo J; Mo C; Chen W
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819844483. PubMed ID: 30987527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single Versus Maintenance Intravesical Chemotherapy for the Prevention of Bladder Recurrence after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Randomized Clinical Trial.
    Harraz AM; El-Shabrawy M; El-Nahas AR; El-Kappany H; Osman Y
    Clin Genitourin Cancer; 2019 Dec; 17(6):e1108-e1115. PubMed ID: 31594736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Conditional Survival with Time of Intravesical Recurrence of Upper Tract Urothelial Carcinoma.
    Shigeta K; Kikuchi E; Hagiwara M; Ando T; Mizuno R; Abe T; Mikami S; Miyajima A; Nakagawa K; Oya M
    J Urol; 2017 Dec; 198(6):1278-1285. PubMed ID: 28634017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?: W. J. Wu, H. L. Ke, Y. H. Yang, C. C. Li, Y. H. Chou and C. H. Huang J Urol 2010; 183: 56-61.
    Mouracade P
    J Urol; 2010 Oct; 184(4):1571. PubMed ID: 20728904
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
    Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
    Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of diagnostic ureteroscopy on intravesical recurrence and survival in patients with urothelial carcinoma of the upper urinary tract.
    Ishikawa S; Abe T; Shinohara N; Harabayashi T; Sazawa A; Maruyama S; Kubota K; Matsuno Y; Osawa T; Shinno Y; Kumagai A; Togashi M; Matsuda H; Mori T; Nonomura K
    J Urol; 2010 Sep; 184(3):883-7. PubMed ID: 20643446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S; Mita K; Shigeta M; Usui T
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravesical irrigation might prevent bladder recurrence in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Yamamoto S; Sakamoto S; Imamura Y; Sazuka T; Nakamura K; Inoue T; Chiba K; Miyazaki K; Inoue A; Nagata M; Ichikawa T
    Int J Urol; 2019 Aug; 26(8):791-796. PubMed ID: 31081198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.